Understanding Adverse Event Reporting in IND Processes for Legal Compliance
Adverse event reporting is a fundamental component of the Investigational New Drug (IND) process, ensuring patient safety and regulatory compliance. Accurate documentation of these events influences drug development and approval outcomes. Understanding the legal and regulatory landscape governing adverse event…